Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiopental Induction Dose during Electroconvulsive Therapy for Depression (TIDE)
2024-519407-99-00Phase 4Authorised
- Sponsor
- Karolinska Institutet
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of thiopental in major depressive disorder (MDD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Change in depressive symptoms after six ECT sessions. Planned start Mar 2025; status: authorised.
02
Drugs
thiopental
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2024-519407-99-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519407-99-00.